Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients.

Viruses - 1 Sept 2021

Deng Xufang, Evdokimova Monika, O'Brien Amornrat, Rowe Cynthia L, Clark Nina M, Harrington Amanda, Reid Gail E, Uprichard Susan L, Baker Susan C

Abstract excerpt

The pandemic of COVID-19 caused by SARS-CoV-2 infection continues to spread around the world. Vaccines that elicit protective immunity have reduced infection and mortality, however new viral variants are arising that may evade vaccine-induced immunity or cause disease in individuals who are unable to develop robust vaccine-induced responses. Investigating the role of viral variants in causing severe disease,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19
Share to Genome, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to Immunocompromised Host

Share to SARS-CoV-2

Share to Severity of Illness Index

Share to Vaccines

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 34578324
DOI: 10.3390/v13091743
PMCID: PMC8472867

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients.PMID 34578324Read ↗

Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalizationSemantic proximity Read ↗

Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concernSemantic proximity Read ↗

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic Diversity.Semantic proximity Read ↗

SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19Semantic proximity Read ↗

SARS-CoV-2 Mutations Responsible for Immune Evasion Leading to Breakthrough InfectionSemantic proximity Read ↗

SARS-CoV-2 Breakthrough Infections in Fully Vaccinated IndividualsSemantic proximity Read ↗

Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City.Semantic proximity Read ↗

Incidence and risk factors of omicron variant SARS-CoV-2 breakthrough infection among vaccinated and boosted individualsSemantic proximity Read ↗

Investigating SARS-CoV-2 breakthrough infections per variant and vaccine typeSemantic proximity Read ↗

Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort studySemantic proximity Read ↗

Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine EffectivenessSemantic proximity Read ↗

Surveillance genome sequencing reveal multiple SARS-CoV-2 variants circulating in the central Texas, USA with a predominance of Delta variant and review of vaccine breakthrough casesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.